59
Growth Score
pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1674593
Intersect Diagnostics is a life science research and development laboratory that focuses on developing proprietary assays.
- Mijanou Van der Woude: Vice President, Operations
- Ed Sitar: Outside Chief Financial OfficerPast Role: Vyant Bio, CFO & Treasurer
About the Company
Intersect Diagnostics is a life science research and development laboratory that focuses on developing proprietary assays with the use of the high-parameter spatial discovery technologies and data analytics to advance the biomarker discovery for precision therapeutics.
The company delivers services for its biotech and biopharma partners by
designing and validating customized, bespoke assays that incorporate both well-known and novel, relatively understudied biomarkers. It deploys these assays in their own, Good Clinical Practice (GCP), a compliant laboratory operating under a robust Quality Management program designed to pass rigorous audits and inspections.
Boaz Kurtis founded it in 2019 and established in Ridgewood, New Jersey.
